← Eichor
Study identifier: NCT07220720 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions

Condition: Prostate  ·  Sponsor: University of Florida

PhasePhase 2
Planned participants30
Who can joinMale, 18 Years to 100 Years
Healthy volunteersNo

About this study

The goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT scan can improve the ability to spot serious prostate cancer in patients who have uncertain MRI results. These uncertain results include MRI results that showed a PIRADS 2 or PIRADS 3 area on the prostate. The investigators want to find out if this new test is better to detect prostate cancer than just doing a biopsy based on MRI alone.

This description comes directly from the study's public registry record.

Talk to the study team

Shelby Sparks  ·  904-244-7340  ·  Urologyresearch@jax.ufl.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UF Health - JacksonvilleJacksonville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07220720